Assertio Holdings, Inc. today announced that management will participate at the following investor conference events during October 2022.
LAKE FOREST, Ill., Oct. 12, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that management will participate at the following investor conference events during October 2022.
| Event: | Windy City Roundup 2022 |
| Date: | Thursday, October 13, 2022 |
| Presentation: | 11:00 a.m. Central Time |
| Location: | Swissotel, Chicago |
| Event: | LD Micro Main Event XV |
| Date: | Tuesday, October 25, 2022 |
| Presentation: | 10:30 a.m. Pacific Time |
| Live stream: | https://me22.mysequire.com/ |
| Location: | Luxe Sunset Boulevard Hotel, Los Angeles |
As part of the conference events, management will host one-on-one meetings throughout the day.
For more information about scheduling a one-on-one meeting with management, please contact your institutional representative for the respective events or Matt Kreps, Investor Relations for Assertio Holdings, at mkreps@darrowir.com.
About Assertio
Assertio Holdings, Inc. is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through business development including licensing, mergers, and acquisitions. For more information regarding Assertio Holdings, go to: https://www.assertiotx.com/.
Investor Contact:
Matt Kreps
Managing Director
Darrow Associates
Austin, TX
M: 214-597-8200
mkreps@darrowir.com
